Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

The Canadian cannabis producer delivered a much-improved performance.

3 Reasons to Give a Big Hooray for Tilray After Its Q4 Update

Tilray, Inc. (TLRY) CEO Brendan Kennedy on Q4 2020 Results - Earnings Call Transcript

Tilray, Inc. (TLRY) delivered earnings and revenue surprises of 42.86% and 1.82%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Tilray, Inc. (TLRY) Reports Q4 Loss, Tops Revenue Estimates

Aphria

Cannabis giant Tilray Inc. (NASDAQ: TLRY) saw revenue climb to $210.5 million in 2020. That's a 26% spike compared to what the Nanaimo, Canada-based company reported for 2019.

Tilray Reports 26% Revenue Spike For 2020, Plans To Close Aphria Deal In Q2

Tilray Inc. narrowed losses and boosted revenue in the final three months of 2020, as it prepared to merge with fellow Canadian marijuana company Aphria Inc.

Tilray pot sales jump ahead of Aphria merger, stock gains more than 10%

NANAIMO, British Columbia--(BUSINESS WIRE)--Tilray, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY), a global pioneer in cannabis research, cultivation, production and distribution, today reported financial results for the full fiscal year and fourth quarter ended December 31, 2020. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated. Brendan Kennedy, Tilray's Chief Executive Officer, stated, “Over the course of 2020, and despite COVID-19 rela

Tilray, Inc. Reports 2020 Full Fiscal Year and Fourth Quarter Results

Aurora Cannabis

Canopy Growth

Cronos Group

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

HEXO Corp

Amplify Alternative Harvest ETF

AdvisorShares Pure US Cannabis ETF

OrganiGram Holdings Inc.

SNDL Inc.

Trulieve Cannabis Corp.

Canadian cannabis stocks have surged in 2021 and a few of them have exhibited irrational exuberance such as Tilray and Sundial. U.S. cannabis stocks continue to trade at a substantial discount despite possessing significantly stronger fundamentals.

Tilray, Sundial May Be In A Bubble But This Group Remains Attractive

Investors appear to be a little jittery about Tilray's fourth-quarter update later today.

Why Aphria and Tilray Stocks Are Falling Today

Each business brings something to the table, but how wise is their decision to combine?

Does the Aphria-Tilray Megamerger Make Either Stock a Buy?

Amplify Seymour Cannabis ETF

Global X Cannabis ETF

AXS Cannabis ETF

Cambria Cannabis ETF

AdvisorShares Vice ETF

AdvisorShares Pure Cannabis ETF 

SPAC Week returns with Joe Crouthers, Co-Founder and CEO of Ceres Group Holdings, who discusses why they're focused on the plant-touching side of the sector. Tying cannabis into traditional business. SPACs more collaborative and less adversarial than traditional IPOs.

SPAC Week II: Why SPACs Make Sense (Podcast Transcript)

Both Tilray and Aphria have seen 200% stock surges in just days from Reddit-style buying. The 'blue wave' will help cannabis companies as federal legalization will open up new markets internally in the United States.

Tilray, Aphria Are On Fire, And Whether You Should Buy In

AMC Entertainment

BlackBerry

GameStop

PayPal

Meme stocks can be hard to time. But one thing is clear -- they will dominate the news in 2021.

Meme Stock Predictions for 2021: Where Will GME, BB, AMC and Bitcoin Go?

TLRY stock investors have a lot of faith in it. Management is likely to live up to the expectations but the stock may not.

Tilray Is Too Wild for Its Own Good

GrowGeneration Corp

The shares of several cannabis companies are trading higher Tuesday as retail investor interest continues to drive the sector higher. The election of Joe Biden as U.S. President and recent Democratic Senate victories in Georgia have also lifted legalization sentiment.

Why Cannabis Stocks Are Trading Higher Today

SunPower

Walmart

Barrick Gold

The holiday-shortened week's earnings reports were set to kick-off with oil and gas independent producer Occidental, but the severe winter weather in Texas forced the company to postpone its report until Monday, February 22.

Earnings Previews: Tilray, SunPower, Barrick and Walmart

The new company will have a comparatively big presence overseas, for one thing.

What Will a Combined Tilray and Aphria Look Like After Their Merger?

Investors seeking to profit from the merger of Canadian cannabis companies Tilray Inc. and Aphria Inc. are best to do so by buying shares of Aphria, which are trading at a 51% discount over the merger conversion price, Cantor Fitzgerald analyst Pablo Zuanic said Tuesday.

Cannabis Watch: To profit from planned merger of Tilray and Aphria, buy Aphria, says this analyst

Silver Spike Acquisition Corp

SPAC Week II: Cannabis SPACs (Podcast)

One analyst says the marijuana company's investors could suffer devastating losses.

Why Tilray Stock Dropped on Friday

SPAC Week returns with Joe Crouthers, Co-Founder and CEO of Ceres Group Holdings, who discusses why they're focused on the plant-touching side of the sector.

SPAC Week, Part II: Why SPACs Make Sense (Podcast)

Moderna

Zynga

Here's how a boutique online game developer, a coronavirus vaccine developer, and the largest cannabis company in the world can all add wealth to your portfolio.

3 Extraordinary Growth Stocks to Buy Now

SPDR S&P 500 ETF Trust

Recall last month, when users of Reddit's popular WallStreetBets forum caused shares of GameStop Corp. (NYSE:GME) to spike by creating a massive short squeeze on the stock. The group also targeted AMC Entertainment Holdings Inc (NYSE:AMC).

This Week In Cannabis: Tilray, Aphria, Sundial Go For A Ride; ETFs Pop With CNBS Advancing 99%

We've seen this story before, and it didn't end well for pot stock investors on the first go-round.

Marijuana Stock Bubble 2.0 Is Here

Koss

Cenntro Electric Group

Cassava Sciences Inc

These momentum stocks have been printing money for retail investors in recent weeks.

5 Stocks That Turned $250,000 Into $1 Million (or More) in 1 Month

NANAIMO, British Columbia--(BUSINESS WIRE)--Tilray Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY), a global pioneer in cannabis production, research, cultivation and distribution, announced today it will report results for 2020 full fiscal year and fourth quarter ended December 31, 2020 on Wednesday, February 17, 2021 after market close. The Company will host a conference call to discuss these results at 5:00 p.m. ET. Investors interested in participating in the live call can dial 877-407-0792

Tilray to Report 2020 Full Fiscal Year and Fourth Quarter Financial Results on February 17, 2021

News for Tilray Brands Stock (TLRY)